|
Dextran fluorescent
|
Dextran that is conjugated to a fluorophore, used for anterograde tract tracing studies in the nervous system
|
ILX:0103179
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dextroamphetamine sulfate
|
An amphetamine sulfate that has formula C18H28N2O4S.
|
ILX:0103180
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dextromethorphan
|
The d-isomer of the codeine analog of levorphanol. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (receptors, N-methyl-D-aspartate) and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity. (PubChem) Pharmacology: Dextromethorphan suppresses the cough reflex by a direct action on the cough center in the medulla of the brain. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity. Mechanism of action: Dextromethorphan is an opioid-like drug that binds to and acts as antagonist to the NMDA glutamatergic receptor, it is an agonist to the opioid sigma 1 and sigma 2 receptors, it is also an alpha3/beta4 nicotinic receptor antagonist and targets the serotonin reuptake pump. Dextromethorphan is rapidly absorbed from the gastrointestinal tract, where it enters the bloodstream and crosses the blood-brain barrier. The first-pass through the hepatic portal vein results in some of the drug being metabolized into an active metabolite of dextromethorphan, dextrorphan, the 3-hydroxy derivative of dextromethorphan. Drug type: Approved. Small Molecule. Drug category: Analgesics, Opioid. Antitussive Agents. Excitatory Amino Acid Antagonists
|
ILX:0103181
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dextrothyroxine
|
The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism. (PubChem) Pharmacology: Dextrothyroxine, the dextrorotary isomer of the synthetic thyroxine, is a antihyperlipidemic. Mechanism of action: Dextrothyroxine is a antihyperlipidemic. The mechanism of action is not completely understood, but dextrothyroxine apparently acts in the liver to stimulate formation of low-density lipoprotein (LDL) and, to a much greater extent, to increase catabolism of LDL. This leads to increased excretion of cholesterol and bile acids via the biliary route into the feces, with a resulting reduction in serum cholesterol and LDL. Dextrothyroxine has no significant effect on high-density lipoproteins (HDL). Drug type: Approved. Small Molecule. Drug category: Antihyperlipidemics
|
ILX:0103182
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dezocine
|
Dezocine is a partial opiate drug and is used for pain management. Dezocine is a very effective alternative to fentanyl when administered during outpatient laparoscopy, although is associated with an increased incidence of postoperative nausea. Pharmacology: Dezocine is a parenteral narcotic analgesic possessing both agonist and antagonist activity. It is similar to morphine with respect to analgesic potency and onset and duration of action. The narcotic antagonist activity is greater than that of pentazocine. Mechanism of action: Dezocine is a opioid receptor antagonist. It binds with stereospecific receptors at many sites within the central nervous system (CNS) to alter processes affecting both the perception of pain and the emotional response to pain. At least 2 of these types of receptors (mu and kappa) mediate analgesia. Mu receptors are widely distributed throughout the CNS, especially in the limbic system (frontal cortex, temporal cortex, amygdala, and hippocampus), thalamus, striatum, hypothalamus, and midbrain as well as laminae I, II, IV, and V of the dorsal horn in the spinal cord. Kappa receptors are localized primarily in the spinal cord and in the cerebral cortex. Drug type: Approved. Small Molecule. Drug category: Analgesics, Opioid
|
ILX:0103183
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Di-n-butyl phthalate
|
Organic Compound;Plasticizer;Aromatic Hydrocarbon;Phthalate; Di-n-butyl phthalate is a manufactured chemical that is added to plastics, paint, glue, hair spray, and other household products. It is commonly found in the environment, and most people are exposed to low levels in the air, water, and food. However, it is believed to have relativel low toxicity.
|
ILX:0103184
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
DiA
|
Green fluorescent carbocyanine dye that is highly lipophilic, used for tract tracing studies in fixed tissue
|
ILX:0103185
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diadenosine tetrahosphate
|
|
ILX:0103186
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diagnostic Interview for Genetic Studies
|
|
ILX:0103187
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diagonal band
|
A white fibre bundle descending in the precommissural septum toward the base of the forebrain, immediately rostral to the lamina terminalis; at the base, the bundle turns in the caudolateral direction; traveling through the ventral substantia innominata alongside the optic tract, it fades before reaching the amygdala. (Mondofacto: http://www.mondofacto.com/facts/dictionary?Broca%27s%20diagonal%20band)
|
ILX:0103188
|
11
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diagonal band nucleus of ABA 2009
|
|
ILX:0103189
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diagonal Domain of CIVM postnatal rat brain atlas
|
The diagonal domain can be segmented on diffusion-weighted images (DWI) in the coronal plane. The rostral extent of the diagonal domain is defined by a dark (high diffusivity) patch at the midline just medial to the light (low diffusivity) accumbens nucleus. The vertical limbs, which also appear dark relative to surrounding tissue, extend ventrolaterally just beneath the row of dark patches that defines the ventral pallidum. Caudally, the dark, horizontal limbs fade away as they extend in to the lateral hypothalamus.
|
ILX:0103190
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diagonal sulcus
|
Sulcus observed in the frontal operculum in some, but not all, humans.
|
ILX:0103191
|
10
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diameter
|
A quality which is equal to the length of any straight line segment that passes through the center of a circle and whose endpoints are on the circular boundary.
|
ILX:0103192
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diamidino yellow
|
Fluorescent diamidino compound used as a retrograde tracer in the nervous system
|
ILX:0103193
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diaphragm
|
A thin musculomebranous barrier that separates the abdominal and thoracic cavities. Often used for breathing control
|
ILX:0103194
|
10
|
scicrunch
|
11/30/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diaphragm Position
|
Positions of diaphragm jaw pairs (in mm) in IEC BEAM LIMITING DEVICE coordinate axis in the IEC order X1, X2, Y1, Y2.
|
ILX:0103195
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
DiAsp
|
Yellow fluorescent carbocyanine dye that is highly lipophilic, used for tract tracing studies in fixed tissue
|
ILX:0103196
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diastatic
|
Separation of normally joined parts, such as the separation of adjacent bones without fracture of certain abdominal muscles during pregnancy.
|
ILX:0103197
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Diazepam
|
A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589) Pharmacology: Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use. Mechanism of action: Benzodiazepines bind nonspecifically to benzodiazepine receptors which mediate sleep, affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. Drug type: Approved. Illicit. Small Molecule. Drug category: Adjuvants, Anesthesia. Anesthetics, Intravenous. Anti-anxiety Agents. Anticonvulsants. Antiemetics. GABA Modulators. Hypnotics and Sedatives. Muscle Relaxants, Central
|
ILX:0103199
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |